Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,875 | 561 | 99.6% |
| Education | $30.96 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,153 | 87 | $0 (2024) |
| PFIZER INC. | $916.59 | 91 | $0 (2024) |
| GlaxoSmithKline, LLC. | $761.10 | 65 | $0 (2024) |
| ABBVIE INC. | $552.25 | 32 | $0 (2024) |
| Astellas Pharma US Inc | $531.12 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $492.29 | 35 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $488.98 | 41 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $336.25 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $333.84 | 20 | $0 (2024) |
| Lilly USA, LLC | $281.06 | 21 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $616.24 | 32 | Novo Nordisk Inc ($166.96) |
| 2023 | $960.82 | 52 | ABBVIE INC. ($161.83) |
| 2022 | $1,307 | 77 | Novo Nordisk Inc ($189.13) |
| 2021 | $1,383 | 96 | Novo Nordisk Inc ($263.75) |
| 2020 | $893.79 | 64 | Novo Nordisk Inc ($211.27) |
| 2019 | $970.03 | 84 | PFIZER INC. ($221.41) |
| 2018 | $875.90 | 82 | PFIZER INC. ($181.79) |
| 2017 | $899.05 | 78 | PFIZER INC. ($201.47) |
All Payment Transactions
565 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Biological | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: Central Nervous System | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Biological | ||||||
| 11/06/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $57.38 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Obesity | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: VACCINES | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: Obesity | ||||||
| 09/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Biological | ||||||
| 08/28/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Central Nervous System | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Endocrinology | ||||||
| 08/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Obesity | ||||||
| 07/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Inflammation | ||||||
| 06/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.78 | General |
| 05/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Obesity | ||||||
| 04/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| Category: Cardiovascular | ||||||
| 04/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 3,070 | 5,252 | $840,796 | $378,074 |
| 2022 | 41 | 2,849 | 4,807 | $768,379 | $367,646 |
| 2021 | 43 | 2,903 | 4,647 | $727,992 | $373,333 |
| 2020 | 54 | 3,515 | 5,377 | $733,384 | $343,497 |
All Medicare Procedures & Services
179 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 294 | 1,011 | $193,458 | $92,095 | 47.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 335 | 381 | $123,552 | $51,001 | 41.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 250 | 493 | $86,443 | $47,089 | 54.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 327 | 738 | $90,920 | $46,182 | 50.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 184 | 184 | $51,750 | $23,776 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 180 | 329 | $44,749 | $21,459 | 48.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 210 | 229 | $57,058 | $21,008 | 36.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 78 | 227 | $32,318 | $11,104 | 34.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 148 | 161 | $22,933 | $10,628 | 46.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 56 | 62 | $39,204 | $10,277 | 26.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 23 | 27 | $12,787 | $5,648 | 44.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 63 | 63 | $4,725 | $4,532 | 95.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $9,108 | $3,644 | 40.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 28 | $6,802 | $3,359 | 49.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $5,760 | $2,650 | 46.0% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 96 | 96 | $5,816 | $2,533 | 43.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 27 | 55 | $6,104 | $2,313 | 37.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 74 | 74 | $2,753 | $2,313 | 84.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 121 | 121 | $5,026 | $2,225 | 44.3% |
| 99236 | Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes | Facility | 2023 | 13 | 13 | $6,383 | $2,073 | 32.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 16 | 49 | $5,835 | $1,901 | 32.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 33 | 36 | $3,949 | $1,700 | 43.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,860 | $1,367 | 47.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 27 | 30 | $3,681 | $1,252 | 34.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 29 | 36 | $2,592 | $946.05 | 36.5% |
About Dr. Jonathan Lovy, D.O
Dr. Jonathan Lovy, D.O is a Internal Medicine healthcare provider based in Trenton, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598777047.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Lovy, D.O has received a total of $7,906 in payments from pharmaceutical and medical device companies, with $616.24 received in 2024. These payments were reported across 565 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($7,875).
As a Medicare-enrolled provider, Lovy has provided services to 12,337 Medicare beneficiaries, totaling 20,083 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 179 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Trenton, MI
- Active Since 08/13/2006
- Last Updated 10/08/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598777047
Products in Payments
- ELIQUIS (Drug) $505.71
- TRELEGY ELLIPTA (Drug) $452.10
- XARELTO (Drug) $410.58
- Ozempic (Drug) $355.90
- CHANTIX (Drug) $348.96
- MYRBETRIQ (Drug) $334.32
- XIFAXAN (Drug) $294.33
- FARXIGA (Drug) $279.20
- UBRELVY (Drug) $221.88
- Wegovy (Drug) $215.78
- Saxenda (Drug) $178.55
- JARDIANCE (Drug) $160.82
- ENTRESTO (Drug) $153.43
- Myrbetriq (Drug) $139.88
- QULIPTA (Drug) $138.06
- VRAYLAR (Drug) $134.85
- GVOKE HYPOPEN (Drug) $125.84
- NURTEC ODT (Drug) $121.39
- ADUHELM (Biological) $118.06
- LYRICA (Drug) $112.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Trenton
Dr. Jane Rohlf, Md, MD
Internal Medicine — Payments: $66,501
Dr. Edward Laub, M.d, M.D
Internal Medicine — Payments: $49,453
Sofia Mavasheva
Internal Medicine — Payments: $21,086
Dr. Anuj Chandra, M.d, M.D
Internal Medicine — Payments: $19,972
Iradj Sharim, M.d, M.D
Internal Medicine — Payments: $14,940
Nilesh Rana, Md, MD
Internal Medicine — Payments: $11,392